Brief: Anteotech Ltd Says European RAT Clinical Trial Halted
Nov 2 (Reuters) - Anteotech Ltd ADO.AX :
* EUROPEAN RAT CLINICAL TRIAL HALTED
* DECISION MADE TO HALT EUGENI SARS-COV-2 AG RDT EUROPEAN
CLINICAL
TRIAL
* TO DIVERT FUNDING FROM TRIAL TO ENABLE ACCELERATION OF
COVID- 19
FLU A / FLU B MULTIPLEX AND/OR OTHER POINT OF CARE (POC) TESTS
* FOR TIME BEING CO HAS MADE DECISION NOT TO PURSUE
ADDITIONAL
REGULATORY APPROVALS FOR SINGLE COVID-19 TEST
Source text for Eikon: ID:nASX3WnVvx
Further company coverage: ADO.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Anteotech
See all newsBrief: Anteotech Says Scott Waddell Resigns As CFO
Brief: Anteotech Discloses Next Generation Battery Agreement With Airspeeder
Brief: Anteotech Announces Anteo S Strategic Collaboration And Sales Agreement
Brief: Anteotech Appoints Scott Waddell As CFO
Brief: Anteotech ADO Expands Into Japan With Life Sciences Distributor